REDWOOD CITY, Calif. and SAN DIEGO, July 7, 2016 /PRNewswire/ — Genomic Health, Inc. (Nasdaq: GHDX) and Epic Sciences, Inc. today announced an exclusive agreement to commercialize Epic Sciences…
Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test to Predict Treatment Response in Metastatic Prostate Cancer
